Ceapro (CVE:CZO) Stock Price Down 11.8% – Should You Sell?

by · The Cerbat Gem

Ceapro Inc. (CVE:CZO – Get Free Report) shares traded down 11.8% on Monday . The stock traded as low as C$0.23 and last traded at C$0.23. 5,850 shares were traded during mid-day trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.

Ceapro Stock Down 11.8%

The stock’s 50 day moving average is C$0.22 and its 200 day moving average is C$0.23. The company has a market capitalization of C$688,880.00, a PE ratio of -2.83 and a beta of 1.38. The company has a debt-to-equity ratio of 8.28, a quick ratio of 18.88 and a current ratio of 7.10.

Ceapro Company Profile

(Get Free Report)

Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.

Read More